Know Cancer

or
forgot password

    • cancer clinical trials in kansas city, KS

    • Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Sarcoma
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    University Of Kansas
    Kansas City, Kansas 66160
    Crohn's Disease
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
    University Of Kansas
    Kansas City, Kansas 66160
    Ulcerative Colitis
    Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US
    GSK Investigational Site
    Kansas City, Kansas 66160
    Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
    Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)
    The University of Kansas Cancer Center
    Kansas City, Kansas 66160
    Chronic Myeloid Leukemia
    Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Breast Cancer
    Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Breast Cancer
    S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    A Pharmacokinetic Study of Melphalan HCL for Injection (Propylene Glycol-Free) and Alkeran for Injection for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
    University of Kansas Medical Center/University of Kansas Cancer Center and Medical Pavillion
    Kansas City, Kansas 66160
    Multiple Myeloma
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer
    Kansas City Cancer Center
    Kansas City, Kansas 66112
    Metastatic Pancreatic Cancer
    Combination of Decitabine and Midostaurin in Patients Older Than 60 With Newly Diagnosed or Relapsed Refractory Acute Myeloid Leukemia
    University of Kansas Medical Center, Westwood Campus
    Kansas City, Kansas 66205
    Acute Myeloid Leukemia
    Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Breast Cancer
    Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Renal Cell Carcinoma
    Telomere and Telomerase
    University of Kansas Medical Center, Westwood Campus
    Kansas City, Kansas 66205
    Acute Myeloid Leukemia
    Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Amyotrophic Lateral Sclerosis
    Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Severe Sepsis
    Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Multiple Sclerosis
    First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC

    Kansas City, Kansas 66160
    Bladder Cancer
    First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
    Kansas City Cancer Center
    Kansas City, Kansas 66112
    Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion, Stage IV Non-small Cell Lung Cancer
    Developing Individualized Strategies to Prevent Nausea and Vomiting
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Postoperative Nausea and Vomiting, Genetic Polymorphisms
    Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Bladder Cancer, Radical Cystectomy, Urinary Bladder Neoplasms, Surgery
    Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
    University of Kansas Cancer Center Univ Kansas 2
    Kansas City, Kansas 66160
    Breast Cancer